Publications and communications of Gillet, Laurent

Denoël, V.* , Bruyère, O.* , Louppe, G., Bureau, F., D'ORIO, V., Fontaine, S., Gillet, L., Guillaume, M., Haubruge, E., Lange, A.-C., Michel, F., Hulle, R. V., Arnst, M., Donneau, A.-F.* , & Saegerman, C.*. (04 March 2022). Decision-based interactive model to determine re-opening conditions of a large university campus in Belgium during the first COVID-19 wave. Archives of Public Health, 80 (1). doi:10.1186/s13690-022-00801-w

Desmecht, S., Tashkeev, A., Nicole Marechal, N., Perée, H., Tokunaga, Y., Fombellida-Lopez, C., Polese, B., Legrand, C., Wéry, M., Mni, M., Fouillien, N., TOUSSAINT, F., Gillet, L., Bureau, F., LUTTERI, L., HAYETTE, M.-P., MOUTSCHEN, M., MEURIS, C., Desmecht, D., & DARCIS, G. (2022). Kinetics and persistence of the cellular and humoral immune responses to BNT162b2 mRNA vaccine in SARS-CoV-2-naive and -experienced subjects. Eprint/Working paper retrieved from https://orbi.uliege.be/2268/267394. doi:10.1101/2022.01.17.22269278

Donneau, A.-F.* , Guillaume, M.* , BOURS, V., Dandoy, M., DARCIS, G., Desmecht, D., Diep, A. N., Fievez, L., Garigliany, M.-M., Gillain, N., Husson, E., Michel, F., MOUTSCHEN, M., Paridans, M., Pétré, B., Sabatel, C., Saegerman, C., Tytgat, A., Gillet, L.* , & Bureau, F.*. (2022). University population-based prospective cohort study of SARS-CoV- 2 infection and immunity (SARSSURV-ULiège): a study protocol. BMJ Open. doi:10.1136/bmjopen-2021-055721

Saegerman, C., Nguyet Diep, A., Renault, V., Donneau, A.-F., Stamatakis, L., Coppieters, W., Michel, F., Breuer, C., Dandoy, M., Ek, O., Gourzonès, C., Schyns, J., Goffin, E., Minner, F., Durkin, K., Artesi, M., Bours, V., Bureau, F., & Gillet, L. (2022). A 2-month field cohort study of SARS-CoV-2 in saliva of BNT162b2 vaccinated nursing home workers. Communications Medicine.

Delguste, M., Brun, G. L., Cotin, F., Machiels, B., Gillet, L., & Alsteens, D. (2021). Single-Virus Force Spectroscopy Discriminates the Intrinsic Role of Two Viral Glycoproteins upon Cell Surface Attachment. Nano Letters, 21 (1), 847-853. doi:10.1021/acs.nanolett.0c04609

Renault, V., Humblet, M.-F., Parisi, G., Donneau, A.-F., Bureau, F., Gillet, L., Fontaine, S., & Saegerman, C. (2021). The First Random Observational Survey of Barrier Gestures against COVID-19. International Journal of Environmental Research and Public Health, 18 (19), 9972. doi:10.3390/ijerph18199972

Loos, P., Maquet, C., Javaux, J., Machiels, B., & Gillet, L. (21 February 2019). A gammaherpesvirus affects type 2 innate lymphoid cells in the context of HDM-induced asthma. Poster session presented at TYPE 2 IMMUNITY IN HOMEOSTASIS AND DISEASE, Bruges, Belgium.

Loos, P., Maquet, C., Javaux, J., Machiels, B., & Gillet, L. (30 November 2018). A gammaherpesvirus affects type 2 innate lymphoid cells in the context of HDM-induced asthma. Poster session presented at The 3rd International Conference on Innate Lymphoid Cells, Tokyo, Japan.

Loos, P., Maquet, C., Javaux, J., Machiels, B., & Gillet, L. (18 July 2018). A gammaherpesvirus affects type 2 innate lymphoid cells in the context of HDM-induced asthma. Poster session presented at Mucosal Immunology Course & Symposium (MICS 2018), Oxford, United Kingdom.

Machiels, B., Dourcy, M., Xiao, X., Javaux, J., Mesnil, C., Sabatel, C., Desmecht, D., LALLEMAND, F., Martinive, P., Hammad, H., Guilliams, M., Dewals, B., Vanderplasschen, A., Lambrecht, B. N., Bureau, F., & Gillet, L. (2018). Correction to: A gammaherpesvirus provides protection against allergic asthma by inducing the replacement of resident alveolar macrophages with regulatory monocytes (Nature Immunology, (2017), 18, 12, (1310-1320), 10.1038/ni.3857). Nature Immunology, 19 (9), 1035. doi:10.1038/s41590-017-0024-8

Machiels, B., & Gillet, L. (2018). L’infection par un herpèsvirus gamma protège l’hôte du développement de l’asthme allergique. MS. Medecine Sciences, 34 (10), 774 - 777. doi:10.1051/medsci/2018199

Zeippen, C., Javaux, J., Xiao, X., Farnir, F., Vanderplasschen, A., Stevenson, P., & Gillet, L. (28 November 2016). Viral glycoprotein gp150 promotes sexual transmission of Murid Herpesvirus-4. Poster session presented at Congrès Annuel de la Société Française d'Immunologie 2016, Paris, France.

Roels, E., Dourcy, M., Holopainen, S., Rajamäcki, M. M., Gillet, L., Ehlers, B., & Clercx, C. (2016). No Evidence of Herpesvirus Infection in West Highland Terriers with Canine Idiopathic Pulmonary Fibrosis. Veterinary Pathology. doi:10.1177/0300985816641991

Roels, E., Dourcy, M., Holopainen, S., Rajamäki, M. M., Gillet, L., & Clercx, C. (October 2015). Canine idopathic pulmonary fibrosis is not associated with herpes virus infection. Poster session presented at 33rd VCRS congress, Edinburgh, United Kingdom.

Boutard, B., Vankerckhove, S., Markine-Goriaynoff, N., Sarlet, M., Desmecht, D., McFadden, G., Vanderplasschen, A., & Gillet, L. (2015). The alpha2,3-Sialyltransferase Encoded by Myxoma Virus Is a Virulence Factor that Contributes to Immunosuppression. PLoS ONE, 10 (2), 0118806. doi:10.1371/journal.pone.0118806

Dourcy, M., Machiels, B., Zeippen, C., Desmecht, D., Vanderplasschen, A., Dewals, B. G., Gillet, L., Dumoulin, J. (Other coll.), & Javaux, J. (Other coll.). (12 December 2014). Murid herpesvirus 4 infection protects mice from the development of an anti-pneumovirus vaccine-induced TH2 immunopathology. Poster session presented at Cell Symposia: The Multifaceted Roles of Type 2 Immunity, Bruges, Belgium.

Krygier, D., Gillet, L., & Marlier, D. (October 2013). La virothérapie oncolytique médiée par le virus de la myxomatose. Annales de Médecine Vétérinaire, 157 (1), 5-14.

Machiels, B., Stevenson, P. G., Vanderplasschen, A., & Gillet, L. (2013). A gammaherpesvirus uses alternative splicing to regulate its tropism and its sensitivity to neutralization. PLoS Pathogens, 9. doi:10.1371/journal.ppat.1003753

Vidick, S., Leroy, B., Palmeira, L., Machiels, B., Mast, J., François, S., Wattiez, R., Vanderplasschen, A., & Gillet, L. (2013). Proteomic characterization of murid herpesvirus 4 extracellular virions. PLoS ONE, 8 (12), 83842. doi:10.1371/journal.pone.0083842

Fournier, G., Boutier, M., Victor, S. R., Mast, J., Parmentier, E., Vanderwalle, P., Peeters, D., Lieffrig, F., Farnir, F., Gillet, L., & Vanderplasschen, A. (25 January 2012). Feeding Cyprinus carpio with infectious materials mediates cyprinid herpesvirus 3 entry through infection of pharyngeal periodontal mucosa. Veterinary Research, 43 (6). doi:10.1186/1297-9716-43-6

Frederico, B., Milho, R., May, J. S., Gillet, L., & Stevenson, P. G. (2012). Myeloid infection links epithelial and B cell tropisms of murid herpesvirus-4. PLoS Pathogens, 8 (9), 1002935. doi:10.1371/journal.ppat.1002935

Glauser, D. L., Kratz, A.-S., Gillet, L., & Stevenson, P. G. (2011). A mechanistic basis for potent, glycoprotein B-directed gammaherpesvirus neutralization. Journal of General Virology, 92 (Pt 9), 2020-33. doi:10.1099/vir.0.032177-0

Machiels, B., Lété, C., Guillaume, A., Mast, J., Stevenson, P. G., Vanderplasschen, A., & Gillet, L. (2011). Antibody evasion by a gammaherpesvirus o-glycan shield. PLoS Pathogens, 7 (11), 1002387. doi:10.1371/journal.ppat.1002387

Palmeira, L., Machiels, B., Lété, C., Vanderplasschen, A., & Gillet, L. (2011). Sequencing of Bovine herpesvirus 4 V.test strain reveals important genome features. Virology Journal, 8 (1), 406. doi:10.1186/1743-422X-8-406

Gillet, L., Colaco, S., & Stevenson, P. G. (2008). The Murid Herpesvirus-4 gL regulates an entry-associated conformation change in gH. PLoS ONE, 3 (7), 2811. doi:10.1371/journal.pone.0002811

Gillet, L., Colaco, S., & Stevenson, P. G. (2008). The murid herpesvirus-4 gH/gL binds to glycosaminoglycans. PLoS ONE, 3 (2), 1669. doi:10.1371/journal.pone.0001669

Fievez, L., Desmet, C., Henry, E., Pajak, B., Hegenbarth, S., Garze, V., Bex, F., Jaspar, F., Boutet, P., Gillet, L., Vanderplasschen, A., Knolle, P. A., Leo, O., Moser, M., Lekeux, P., & Bureau, F. (2007). Stat5 Is an Ambivalent Regulator of Neutrophil Homeostasis. PLoS ONE, 2 (1), 727. doi:10.1371/journal.pone.0000727

Gillet, L., Adler, H., & Stevenson, P. G. (2007). Glycosaminoglycan interactions in murine gammaherpesvirus-68 infection. PLoS ONE, 2 (4), 347. doi:10.1371/journal.pone.0000347

Gillet, L., May, J. S., Colaco, S., & Stevenson, P. G. (2007). The murine gammaherpesvirus-68 gp150 acts as an immunogenic decoy to limit virion neutralization. PLoS ONE, 2 (1), 705. doi:10.1371/journal.pone.0000705

Gillet, L., May, J. S., & Stevenson, P. G. (2007). Post-exposure vaccination improves gammaherpesvirus neutralization. PLoS ONE, 2 (9), 899. doi:10.1371/journal.pone.0000899

Rosa, G. T., Gillet, L., Smith, C. M., de Lima, B. D., & Stevenson, P. G. (2007). IgG fc receptors provide an alternative infection route for murine gamma-herpesvirus-68. PLoS ONE, 2 (6), 560. doi:10.1371/journal.pone.0000560